These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 11266963

  • 1. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation.
    Yanagida N, Nomura M, Yamashita K, Takehara M, Murakami M, Echizenya H, Konishi K, Kitagawa N, Furukawa H, Uede T, Todo S.
    Transplant Proc; 2001; 33(1-2):573-4. PubMed ID: 11266963
    [No Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats.
    Echizenya H, Yamashita K, Takehara M, Konishi K, Nomura M, Yanagida N, Kitagawa N, Kobayashi T, Furukawa H, Inobe M, Uede T, Todo S.
    Transplant Proc; 2001; 33(1-2):183-4. PubMed ID: 11266771
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival.
    Namii Y, Hayashi S, Yokoyama I, Kobayashi T, Yasutomi M, Nagasaka T, Uchida K, Hamada H, Takagi H.
    Transplant Proc; 1997 May; 29(3):1738-9. PubMed ID: 9142255
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated gene transfer of CTLA4Ig to liver allografts results in prolonged survival and local T-cell anergy.
    Olthoff KM, Da Chen X, Gelman A, Turka L, Shaked A.
    Transplant Proc; 1997 May; 29(1-2):1030-1. PubMed ID: 9123183
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of adenoviral-mediated CTLA4-IG gene-induced pancreatic allograft tolerance in rats.
    Liu C, Deng S, Jiang K, Gelman A, Shaked A, Brayman KL.
    Transplant Proc; 2001 May; 33(1-2):134. PubMed ID: 11266743
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged survival of heart allograft.
    Hayashi S, Guang-Lin M, Yokoyama I, Namii Y, Hamada H, Nakao A.
    Transpl Int; 2000 May; 13 Suppl 1():S329-32. PubMed ID: 11112025
    [Abstract] [Full Text] [Related]

  • 11. Gene gun-mediated CTLA4Ig-gene transfer for modification of allogeneic cardiac grafts.
    Umeda Y, Iwata H, Yoshikawa S, Matsuno Y, Marui T, Nitta T, Idia Y, Takagi H, Mori Y, Miyazaki J, Kosugi A, Hirose H.
    Transplant Proc; 2002 Nov; 34(7):2622-3. PubMed ID: 12431548
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts.
    Chen Z, Lu L, Li J, Li W, Fung JJ, Xiao X, Qian S.
    Transplant Proc; 2001 Nov; 33(1-2):604. PubMed ID: 11266978
    [No Abstract] [Full Text] [Related]

  • 14. Local production of CTLA4-Ig by adenoviral-mediated gene transfer to the pancreas induces permanent allograft survival and donor-specific tolerance.
    Liu C, Deng S, Yang Z, Kucher T, Guo F, Gelman A, Chen H, Naji A, Shaked A, Brayman KL.
    Transplant Proc; 1999 Nov; 31(1-2):625-6. PubMed ID: 10083267
    [No Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig.
    Olthoff KM, Judge TA, Gelman AE, da Shen X, Hancock WW, Turka LA, Shaked A.
    Nat Med; 1998 Feb; 4(2):194-200. PubMed ID: 9461193
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated gene transfer of CTLA4IG gene results in prolonged survival of heart allograft.
    Guang-Lin M, Hayashi S, Yokoyama I, Namii Y, Kobayashi T, Katayama A, Nagasaka T, Hamada H, Negita M, Takagi H.
    Transplant Proc; 1998 Nov; 30(7):2923-4. PubMed ID: 9838288
    [No Abstract] [Full Text] [Related]

  • 17. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig.
    Iwasaki N, Gohda T, Yoshioka C, Murakami M, Inobe M, Minami A, Uede T.
    Transplantation; 2002 Feb 15; 73(3):334-40. PubMed ID: 11884927
    [Abstract] [Full Text] [Related]

  • 18. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting.
    Kita Y, Li XK, Funeshima N, Enosawa S, Tamura A, Hayashi S, Suzuki K, Kazui T, Amemiya H, Suzuki S.
    Transplant Proc; 1999 Nov 15; 31(7):2787-8. PubMed ID: 10578291
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of CTLA4Ig gene transfer with adenovirus vector on allogeneic renal graft survival in the rat].
    Shindo J.
    Hokkaido Igaku Zasshi; 2001 Jul 15; 76(4):251-61. PubMed ID: 11523116
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
    Jin Y, Zhang Q, Hao J, Gao X, Guo Y, Xie S.
    Immunology; 2003 Oct 15; 110(2):275-86. PubMed ID: 14511242
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.